OpenFilings
Damora Therapeutics, Inc.
Form
8-K
Report Period
2026-02-06
Date Filed
2026-02-10
Time Filed
08:00:50
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-3.1
Filing on SEC Edgar